From eNewsletter 8/26/2024
DID YOU KNOW that the herb andrographis, which you should be very familiar with because it is our "go-to" antiviral support at first hint of COVID infection, also contains a phytochemical that is being investigated as a lead compound in cancer drug development, according to two studies from Drug Discovery Today and Current Drug Delivery?
According to the authors of the Current Drug Delivery study: "Andrographolide, a diterpene lactone separated from Andrographis paniculata, has also been shown to have important critical essential biological protective properties. It has also been suggested that it could be used to treat major human diseases like rheumatoid, colitis, and Parkinsons disease. This study aims to highlight Andrographolide as a promising cancer treatment option."
To read the rest of today's issue, please go to this page.
Comments